Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 14, 2022, Axon Enterprise, Inc. (the "Company") announced that Luke S. Larson, the Company's President, will be returning from medical leave and effective December 31, 2022 will transition from the role of President to strategic advisor.

The Company announced on May 26, 2022 that Mr. Larson had begun a medical leave of absence due to a serious, treatable health issue and that Joshua M. Isner had been promoted to Chief Operating Officer. While serving in his new non-officer capacity at Axon, Mr. Larson will be advising the company on its growth initiatives.

"Luke's contributions to the success of Axon's entire business cannot be overstated, including having helped us to establish and grow our software and sensor business from an idea to the global market leading position we enjoy today," Axon Chief Executive Officer Rick Smith said. "We are thrilled that he will continue to support Axon in this strategic capacity as an advisor."

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit No.   Description
101           Cover Page Interactive Data File - the cover page XBRL tags are
              embedded within the Inline XBRL document
104           The cover page from this Current Report on Form 8-K, formatted as
              Inline XBRL

© Edgar Online, source Glimpses